Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Brainsway Ltd. Sponsored ADR (BWAY) vs Pacific Biosciences of California, Inc. (PACB)

Brainsway Ltd. Sponsored ADR and Pacific Biosciences of California, Inc. are both Medical Devices companies. Brainsway Ltd. Sponsored ADR and Pacific Biosciences of California, Inc. are of similar size ($531.6M and $484.9M). Pacific Biosciences of California, Inc. has negative trailing earnings, so its P/E is not meaningful; Brainsway Ltd. Sponsored ADR trades at 28.9×. Brainsway Ltd. Sponsored ADR grew revenue faster over the last twelve months: 31.7% against 2.02%. Brainsway Ltd. Sponsored ADR has the higher net margin (15.6% vs −82.5%) and the higher return on invested capital (30.0% vs −22.2%). Across the 17 metrics below, Brainsway Ltd. Sponsored ADR leads on 14 and Pacific Biosciences of California, Inc. on 3.

Valuation

Metric BWAY PACB Medical Devices median
P/E 28.93 n/m 22.18
P/S 4.24 3.16 2.70
P/B 3.25 n/m 2.46
Price to free cash flow 44.53 n/m 22.53
EV/EBITDA 21.60 n/m 11.78
EV/Sales 3.28 5.72 2.38
Earnings yield 3.46% (26.54%) (8.22%)
Free cash flow yield 2.25% (15.99%) (7.80%)

Profitability

Metric BWAY PACB Medical Devices median
Gross margin 75.32% 36.38% 56.01%
Operating margin 12.46% (83.53%) (15.03%)
Net margin 15.55% (82.49%) (20.40%)
Free cash flow margin 9.53% (50.53%) (7.24%)
Return on equity 12.82% (929.31%) (15.32%)
Return on assets 8.09% (16.66%) (19.72%)
Return on invested capital 29.98% (22.22%) (10.33%)

Growth

Metric BWAY PACB Medical Devices median
Revenue growth (TTM) 31.71% 2.02% 8.80%
EPS growth (last fiscal year) 114.29% (69.38%) —
Revenue growth, 5-year CAGR 18.81% 15.19% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BWAY PACB Medical Devices median
Debt to equity 0.00 (19.40) 0.07
Current ratio 3.59 4.92 2.50
Net debt to EBITDA (11.84) (2.33) 0.49

Dividend

Metric BWAY PACB Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric BWAY PACB Medical Devices median
Market cap 531.57m 484.89m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack